 efficaci octreotid acet treatment sever postgastrectomi syndrom present studi acut chronic use long-act somatostatin analog octreotid acet treatment patient sever postgastrectomi syndrom acut phase patient sever consecut day hour ingest breakfast random double-blind fashion day microgram minut test meal day equal volum vehicl addit group postgastrectomi patient similar fashion control placebo treatment test meal immedi increas puls rate plasma level glucos glucagon pancreat polypeptid neurotensin insulin similar chang control group respect placebo glucagon neurotensin magnitud increas placebo treatment octreotid acet develop vasomotor gastrointestin symptom respons plasma peptid chang complet ablat diarrhea pretreat octreotid acet rise plasma insulin respons meal late hypoglycemia treatment octreotid acet delay gastric empti transit time minut minut placebo minut control chronic daili treatment octreotid acet minim side effect patient stabl fast plasma glucos normal liver function test averag weight gain period addit patient abl employ long-act somatostatin analog octreotid acet effect develop symptom sever syndrom vasomotor gastrointestin